Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy

Published:2024-04 Issue: Volume:46 Page:67-69
ISSN:2352-5126
Container-title:JAAD Case Reports
language:en
Short-container-title:JAAD Case Reports

Author:

González-Cruz Carlos,Muñoz-Couselo Eva,Ortiz-Velez Carolina,Ferrer Berta,García-Patos Vicente,Ferrándiz-Pulido Carla

Funder

Sun Pharma

Publisher

Elsevier BV

Reference7 articles.

1. Sonidegib as a locally advanced basal cell carcinoma therapy in real-life clinical setting: a national multicentre study;Moreno-Arrones;Actas Dermosifiliogr,2023

2. PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma;Migden;N Engl J Med,2018

3. Complete response of advanced cutaneous squamous cell and basal cell carcinomas with sequential cemiplimab and sonidegib therapy;Weis;J Eur Acad Dermatol Venereol,2022

4. The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: two case reports;Colombo;Front Oncol,2023

5. Pembrolizumab monotherapy for recurrent or metastatic cutaneous squamous cell carcinoma: a single-arm phase II trial (KEYNOTE-629);Grob;J Clin Oncol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP